The CDK4 gene helps control when cells grow and divide. The protein made by this gene helps your cells pass a key checkpoint before they copy their DNA, and if this control is lost, cells may multiply in a less controlled way. A small number of inherited CDK4 variants are linked to familial melanoma, a form of skin cancer that can run in families. CDK4 became more widely known in cancer care as drugs that block CDK4 and CDK6 began to be used for some breast cancers.
What is a gene?
Genes are sections of DNA that hold instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for making proteins, the parts of cells that do much of the work. Others mainly help manage when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, more information is available in the LearnHub.
Overview
CDK4Gene function
What if the gene works
The CDK4 gene helps control when cells grow and divide. Its protein works with partner proteins to move cells through the cell cycle in a controlled way.
Risk
What if the gene does not work
Certain variants in the CDK4 gene can increase the chance of hereditary melanoma, often with several melanomas appearing over time. Effects can vary, with milder or more severe variants influencing how early melanoma develops and the level of risk.
Treatment
What does that mean for your treatment
No CDK4-specific treatment or management approach is currently established for people with a pathogenic or loss-of-function variant in the CDK4 gene. The CDK4 gene is an important drug target in cancer care, and CDK4/6 inhibitors are used in some cancers based on tumor type and other tumor features, not on an inherited CDK4 variant alone.
Conditions associated with CDK4
Gene function
What if the gene works
Many tissues stay healthy by replacing old cells in a controlled way. The CDK4 gene helps set the pace for that process when cells receive signals to grow and divide. Understanding what the CDK4 gene does in the body helps explain how cell renewal stays orderly.
This gene helps move cells through the early part of the cell cycle, the step by step process cells use to prepare for division. It helps keep growth orderly and supports division at the right time.
Its protein helps cells translate normal growth signals into a clear go ahead to divide. This lets tissues adjust cell production to everyday needs.
Working with cyclin D proteins, the CDK4 gene becomes active when conditions are suitable for growth. It then adds a small chemical tag to key control proteins, which helps start the next phase before DNA is copied.
By supporting controlled cell division, the CDK4 gene helps maintain tissues that need regular replacement, such as skin and the lining of the gut. This steady turnover helps your body manage routine wear and repair.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including traits such as appearance, metabolism, and the way the body responds to environmental factors. Many variants do not have any noticeable effect and are part of natural genetic variation. In some situations, though, a variant changes how a gene works more strongly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Some changes in the CDK4 gene show how CDK4 variants affect cell growth signals by altering protein shape, activity, or response to natural brakes. Activating variants, especially at position 24, can block shutoff by p16, a natural brake on cell division, so signaling lasts longer. Other variants may be milder and partly change partner binding, while more disruptive ones can reduce activity or make the protein unstable. In melanoma-linked CDK4 variants, stronger activating effects often mean a clearer cancer risk.
How variants are linked to conditions
Rare inherited variants in the CDK4 gene are linked to hereditary melanoma, especially in families with several relatives affected or more than one melanoma in the same person. This CDK4 gene melanoma risk is well established but uncommon. People with a pathogenic variant may also have atypical moles and may develop melanoma at a younger age than usual.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors are involved. In some situations, though, a single well characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For inherited CDK4 changes linked to familial melanoma, risk is strongly shaped by the variant itself. Sun and tanning bed exposure can further raise melanoma risk, and having fair skin or many moles may add to that risk. There is not enough evidence to say lifestyle changes remove the inherited risk, but careful sun protection and skin checks can help with early detection.
Inheritance of CDK4 variants
CDK4-related familial melanoma is usually inherited in an autosomal dominant pattern. If you carry a disease-causing variant in the CDK4 gene, each child has a 50% chance of inheriting that same variant. A parent with the variant can pass it to a son or daughter, and either sex can inherit it. In families affected by this condition, this is the established CDK4 inheritance pattern.
What does my CDK4 result mean for my family?
For CDK4, the family pattern is usually dominant, which means a close relative like a parent, brother, sister, or child may also carry the same change. In families with a disease-causing CDK4 variant, several relatives across generations can have a higher chance of melanoma, especially if there is a strong family history of skin cancer. Because of that, first-degree relatives may also want to learn whether the variant is present in the family.
Genetic information
Genetic testing
How you find out about variants
CDK4 genetic testing usually uses a blood or saliva sample to read the CDK4 gene and look for inherited variants linked with familial melanoma risk. Labs sequence the gene, sometimes as part of a broader skin cancer panel, and results may show a pathogenic variant, a benign change, or a variant of uncertain significance.
When should I consider getting a genetic test?
You may want to consider genetic testing for CDK4 if you or several close relatives have had melanoma, a serious type of skin cancer, especially at younger ages or if one person has had more than one melanoma. A harmful change in CDK4 can point to an inherited risk and may help guide skin checks and family testing.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it can tell you varies based on the condition and the specific type of variant involved. Many other factors also shape how the body functions over time, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most helpful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put a person’s individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is absorbed, broken down, transported, or how strongly it acts in the body, so the same treatment may work better for some people than for others. This is common and can influence how much benefit a medicine gives or how likely someone is to have side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medications. It studies connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strong a drug’s effect is or how the body handles it. This information can support more informed and more individualized treatment decisions. If you want to read more about this topic, you can learn more in the LearnHub.
Drugs influenced by the CDK4 gene
When should I seek medical advice?
There isn’t yet a broadly confirmed role for this gene in guiding everyday medication choices, so general questions about side effects, new symptoms, or how medicines may affect you are best discussed with your doctor. In cancer care, CDK4 changes in a tumor are being studied for how they may relate to response to CDK4/6 inhibitor medicines, but this is still a specialist area.
History
The CDK4 gene entered cancer research as scientists worked out how cells move through the growth cycle in the late 20th century. From these first observations, research expanded steadily. In the 1990s, studies linked changes in the CDK4 gene to melanoma in some families, which helped show that inherited cancer risk could involve genes controlling cell division. Around the same time, CDK4 became part of a broader shift in biology as researchers mapped the checkpoints that guide when cells grow and when they pause. That work helped lay the foundation for later cancer medicines designed to target the CDK4 pathway. Today, the CDK4 gene is best known as one of the key genes that shaped modern understanding of cell cycle driven cancers.